You're currently viewing an old version of this dataset. To see the current version, click here.

HIV drug resistance testing application form (version2, 2022)

This form is used for requesting the National HIV drug resistance (HIVDR) Expert Committee Patients to review a patient with confirmed viral failure for potential drug resistance testing. Patients on DTG- and PI-based regimens who don’t re-suppress below 1000 copies/ml after an initial high VL despite good adherence need a genotype sample for resistance testing.
Contact the HIVDR Expert Committee, either through the Department of HIV, STI and Viral Hepatitis, or by sending an email to 3rdlineart@lighthouse.org.mw.
Follow the instructions on the application form and ensure that the application form is completely filled before sending it to the expert committee.
The expert committee will advise if a genotype sample needs to be collected. Genotyping is only possible if the current VL is 1000+ and will be more reliable from 5000+.
The genotype result can only be interpreted correctly if the patient has been taking their ARVs consistently for 2-3 months before the sample was collected.
Maintain the current regimen until genotyping results are available.
Follow the regimen recommendations from the National HIVRDR expert committee.

Data and Resources